JC: Epistaxis – The NoPAC trial – Does TXA work?
Is Tranexamic Acid a useful adjunct in the management of epistaxis
JC: Epistaxis – The NoPAC trial – Does TXA work? Read More
dom9
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s
In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More
JC: Canadian TIA risk score. St Emlyn’s
We see a lot of patients in the ED with a history of what sounds very much like a transient ischaemic event (TIA). By definition the patient will have had
JC: Canadian TIA risk score. St Emlyn’s Read More
Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s
Oxygen targets in critically ill/injured patients has been something we’ve talked about on the blog before. In general the evidence to date has suggested that the routine prescription of oxygen
Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s Read More
Vaccines update January 2021: St Emlyn’s
Rick Body has once again put together a great COVID-19 podcast to update us on the latest vaccines roll out in the UK. Prof. Rick Body, Prof. Simon Carley, Prof.
Vaccines update January 2021: St Emlyn’s Read More
#FOAMed for academics: A primer. St Emlyn’s
This week I’m (virtually) attending the RCEM Research Engagement Day. This annual event combined an academic trainee day (14th) together with a more general day looking at research in a
#FOAMed for academics: A primer. St Emlyn’s Read More
JC: Lopinavir/Ritonavir in the treatment of COVID-19
We have been following the RECOVERY trial closely over the last few months. It’s the largest RCT of therapeutics for COVID-19 in the world and it’s already shown that hydroxychloroquine
JC: Lopinavir/Ritonavir in the treatment of COVID-19 Read More
JC: Azithromycin in patients hospitalised with COVID-19
As we near the end of 2020, it is worth taking a moment to reflect on what a year it has been. At the beginning of the year we were
JC: Azithromycin in patients hospitalised with COVID-19 Read More